Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Muscular Atrophy × ostarine × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Lymphoid 1 Gastrointestinal 1

Conditions

ER+ and AR+ Breast Cancer 2 Triple Negative Breast Neoplasms 1 Muscular Atrophy 1 Lymphoma, Non-Hodgkin 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Cachexia 1 Breast Neoplasms 1

Interventions

ostarine 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00467844 2014-07-11

Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.

GTx

Phase 2 Completed

159 enrolled 11 charts

GastrointestinalLymphoidThoracic

Cachexia, Carcinoma, Non-Small-Cell Lung, Lymphoma, Non-Hodgkin, Muscular Atrophy, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡